Zhang J et al. |
15-Deoxy-prostaglandin J(2) inhibits PDGF-A and -B chain expression in human vascular endothelial cells independent of PPAR gamma. |
2002 |
Biochem. Biophys. Res. Commun. |
pmid:12379230
|
Clay CE et al. |
15-Deoxy-delta12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. |
2002 |
J. Lipid Res. |
pmid:12401880
|
Imaizumi T et al. |
15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. |
2002 |
Immunol. Cell Biol. |
pmid:12406386
|
Jawerbaum A et al. |
Modulation of nitric oxide concentration and lipid metabolism by 15-deoxy Delta12,14prostaglandin J2 in embryos from control and diabetic rats during early organogenesis. |
2002 |
Reproduction |
pmid:12417000
|
Fahmi H et al. |
15d-PGJ(2) is acting as a 'dual agent' on the regulation of COX-2 expression in human osteoarthritic chondrocytes. |
2002 |
Osteoarthr. Cartil. |
pmid:12435328
|
Nikitakis NG et al. |
15-PGJ2, but not thiazolidinediones, inhibits cell growth, induces apoptosis, and causes downregulation of Stat3 in human oral SCCa cells. |
2002 |
Br. J. Cancer |
pmid:12454768
|
Badawi AF and Badr MZ |
Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. |
2003 |
Int. J. Cancer |
pmid:12455057
|
Okada M et al. |
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. |
2002 |
FASEB J. |
pmid:12468449
|
Winnett G et al. |
Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. |
2003 |
Int. J. Cancer |
pmid:12494466
|
Weber SM et al. |
Inhibition of IFN-gamma -induced STAT1 activation by 15- deoxy-Delta 12,14-prostaglandin J2. |
2003 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:12517740
|